Ajanta Pharma Limited has submitted a regulatory disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimating its schedule of upcoming meetings with analysts and institutional investors.
The company has provided the following schedule of meetings:
- Meeting 1: Conference scheduled from 11th to 13th August 2026 as part of the Nuvama India Conference 2026 (Singapore & Hong Kong Edition). The format will be one-on-one meetings, and the locations will be Singapore and Hong Kong.
- Meeting 2: Scheduled for 18th August 2026 as part of the Motilal Annual Global Conference. The venue is specified as Grand Hyatt, Santacruz.
The disclosure includes an important qualification that this schedule is subject to change due to exigencies on either side (the company or the participants).
The company explicitly confirms that all discussions during these meetings will be strictly based on already published information, indicating that no new, material, unpublished price-sensitive information (UPSI) will be shared.